Obesity and insulin resistance in women with polycystic ovary syndrome

Hsu Chun-Sen, Wu Chien-Hua, Chiu Wan-Chun, Lee Ching-Tzu, Chang Chun-Jen, Hsu Ming-I

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective. To evaluate the impact of obesity and various phenotypes of polycystic ovary syndrome (PCOS) on the insulin sensitivity index (ISI) and insulin resistance (IR). Methods. ISI and IR from 273 women in four phenotypes of PCOS and control groups were evaluated retrospectively. Results. The ISI and the percentage of IR were not significantly different among discrete phenotypes of PCOS groups and normal controls. Obesity (OR = 14.0, 95% CI (Confidence Interval), 7.5-26.5) results in a higher risk for developing insulin resistance than hyperandrogenemia (OR = 2.1, 1.3-3.6), oligomenorrhea (OR = 1.8, 1.0-3.3) and polycystic ovary morphology (PCOM) (OR = 1.4, 0.8-2.7). Conclusion. The ISI did not differ significantly among the various phenotypes of PCOS. In comparison with hyperandrogenemia, chronic anovulation, and PCOM, obesity was the dominant risk factor in determining insulin resistance in women with PCOS.

Original languageEnglish
Pages (from-to)300-306
Number of pages7
JournalGynecological Endocrinology
Volume27
Issue number5
DOIs
Publication statusPublished - May 2011

Fingerprint

Polycystic Ovary Syndrome
Insulin Resistance
Obesity
Phenotype
Ovary
Oligomenorrhea
Anovulation
Control Groups
Confidence Intervals

Keywords

  • insulin resistance
  • obesity
  • phenotypes
  • Polycystic ovary syndrome

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Obstetrics and Gynaecology

Cite this

Obesity and insulin resistance in women with polycystic ovary syndrome. / Chun-Sen, Hsu; Chien-Hua, Wu; Wan-Chun, Chiu; Ching-Tzu, Lee; Chun-Jen, Chang; Ming-I, Hsu.

In: Gynecological Endocrinology, Vol. 27, No. 5, 05.2011, p. 300-306.

Research output: Contribution to journalArticle

Chun-Sen, Hsu ; Chien-Hua, Wu ; Wan-Chun, Chiu ; Ching-Tzu, Lee ; Chun-Jen, Chang ; Ming-I, Hsu. / Obesity and insulin resistance in women with polycystic ovary syndrome. In: Gynecological Endocrinology. 2011 ; Vol. 27, No. 5. pp. 300-306.
@article{e34188b312e345b9b864e3a4fdfe77f9,
title = "Obesity and insulin resistance in women with polycystic ovary syndrome",
abstract = "Objective. To evaluate the impact of obesity and various phenotypes of polycystic ovary syndrome (PCOS) on the insulin sensitivity index (ISI) and insulin resistance (IR). Methods. ISI and IR from 273 women in four phenotypes of PCOS and control groups were evaluated retrospectively. Results. The ISI and the percentage of IR were not significantly different among discrete phenotypes of PCOS groups and normal controls. Obesity (OR = 14.0, 95{\%} CI (Confidence Interval), 7.5-26.5) results in a higher risk for developing insulin resistance than hyperandrogenemia (OR = 2.1, 1.3-3.6), oligomenorrhea (OR = 1.8, 1.0-3.3) and polycystic ovary morphology (PCOM) (OR = 1.4, 0.8-2.7). Conclusion. The ISI did not differ significantly among the various phenotypes of PCOS. In comparison with hyperandrogenemia, chronic anovulation, and PCOM, obesity was the dominant risk factor in determining insulin resistance in women with PCOS.",
keywords = "insulin resistance, obesity, phenotypes, Polycystic ovary syndrome",
author = "Hsu Chun-Sen and Wu Chien-Hua and Chiu Wan-Chun and Lee Ching-Tzu and Chang Chun-Jen and Hsu Ming-I",
year = "2011",
month = "5",
doi = "10.3109/09513590.2010.488776",
language = "English",
volume = "27",
pages = "300--306",
journal = "Gynecological Endocrinology",
issn = "0951-3590",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Obesity and insulin resistance in women with polycystic ovary syndrome

AU - Chun-Sen, Hsu

AU - Chien-Hua, Wu

AU - Wan-Chun, Chiu

AU - Ching-Tzu, Lee

AU - Chun-Jen, Chang

AU - Ming-I, Hsu

PY - 2011/5

Y1 - 2011/5

N2 - Objective. To evaluate the impact of obesity and various phenotypes of polycystic ovary syndrome (PCOS) on the insulin sensitivity index (ISI) and insulin resistance (IR). Methods. ISI and IR from 273 women in four phenotypes of PCOS and control groups were evaluated retrospectively. Results. The ISI and the percentage of IR were not significantly different among discrete phenotypes of PCOS groups and normal controls. Obesity (OR = 14.0, 95% CI (Confidence Interval), 7.5-26.5) results in a higher risk for developing insulin resistance than hyperandrogenemia (OR = 2.1, 1.3-3.6), oligomenorrhea (OR = 1.8, 1.0-3.3) and polycystic ovary morphology (PCOM) (OR = 1.4, 0.8-2.7). Conclusion. The ISI did not differ significantly among the various phenotypes of PCOS. In comparison with hyperandrogenemia, chronic anovulation, and PCOM, obesity was the dominant risk factor in determining insulin resistance in women with PCOS.

AB - Objective. To evaluate the impact of obesity and various phenotypes of polycystic ovary syndrome (PCOS) on the insulin sensitivity index (ISI) and insulin resistance (IR). Methods. ISI and IR from 273 women in four phenotypes of PCOS and control groups were evaluated retrospectively. Results. The ISI and the percentage of IR were not significantly different among discrete phenotypes of PCOS groups and normal controls. Obesity (OR = 14.0, 95% CI (Confidence Interval), 7.5-26.5) results in a higher risk for developing insulin resistance than hyperandrogenemia (OR = 2.1, 1.3-3.6), oligomenorrhea (OR = 1.8, 1.0-3.3) and polycystic ovary morphology (PCOM) (OR = 1.4, 0.8-2.7). Conclusion. The ISI did not differ significantly among the various phenotypes of PCOS. In comparison with hyperandrogenemia, chronic anovulation, and PCOM, obesity was the dominant risk factor in determining insulin resistance in women with PCOS.

KW - insulin resistance

KW - obesity

KW - phenotypes

KW - Polycystic ovary syndrome

UR - http://www.scopus.com/inward/record.url?scp=79953808748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953808748&partnerID=8YFLogxK

U2 - 10.3109/09513590.2010.488776

DO - 10.3109/09513590.2010.488776

M3 - Article

C2 - 20500115

AN - SCOPUS:79953808748

VL - 27

SP - 300

EP - 306

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

IS - 5

ER -